Jingjing Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jingjing Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Feng Suo
Center for Genetic Medicine, Xuzhou Maternity and Child Health Care Hospital Affiliated to Xuzhou Medical University
1 shared publication - Liang Lv
Gynecology Department of Xuzhou Maternal and Child Health Hospital Xuzhou Jiangsu China
1 shared publication - Lingshan Gou
Center for Genetic Medicine, Xuzhou Maternity and Child Health Care Hospital Affiliated to Xuzhou Medical University
1 shared publication - Tong Zhu
Reproductive Medicine Department of Xuzhou Maternal and Child Health Hospital Xuzhou Jiangsu China
1 shared publication - Xin Yin
Center for Genetic Medicine, Xuzhou Maternity and Child Health Care Hospital Affiliated to Xuzhou Medical University
1 shared publication - Yijuan Cao
Center for Reproductive Medicine, XuZhou Central Hospital, Southeast University, Xuzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Endocrinology
- Vol. 2026 (1)
Glycoursodeoxycholic Acid and Insulin Resistance in Women With Normoandrogenic Polyendocrine Metabolic Ovarian Syndrome Undergoing In Vitro Fertilization
Aim: To characterize paired serum and follicular fluid (FF) bile acids in normoandrogenic polyendocrine metabolic ovarian syndrome (NA‐PMOS) and investigate associations of glycoursodeoxycholic acid (GUDCA) with endocrine‐metabolic indices and in vitro fertilization (IVF) outcomes. Methods: This retrospective case–control study included 20 women with NA‐PMOS and 20 age‐comparable controls without PMOS undergoing IVF. Fifteen bile acids were measured in serum and FF. Analyses assessed group differences, metabolic and IVF associations, and discrimination between diagnostic groups. Results: Compared with controls without PMOS, women with NA‐PMOS had higher fasting insulin, triglycerides, and triglyceride–glucose (TyG) index and a lower high‐quality embryo rate. GUDCA was lower in NA‐PMOS in FF (137.01 vs. 332.60 nmol/L; p = 0.0004768; q = 0.007152) and serum (31.59 vs. 71.85 nmol/L; p = 0.03022; q = 0.2704). Apparent areas under the curve (AUCs) were 0.849 for FF, 0.713 for serum, and 0.871 for their combination. Serum GUDCA correlated inversely with TyG ( ρ = −0.582, p = 0.0028); the association persisted after adjustment for age, BMI, and diagnostic group ( β = −0.348, p = 0.0415). Within NA‐PMOS, serum GUDCA correlated inversely with fasting insulin and homeostasis model assessment of insulin resistance (HOMA‐IR). In the pooled cohort, FF GUDCA correlated inversely with baseline anti‐Müllerian hormone, total testosterone, and oocyte counts. GUDCA in neither matrix was significantly associated with high‐quality embryo rate. Conclusions: Lower GUDCA in serum and FF characterizes this exploratory IVF‐based NA‐PMOS sample, with stronger between‐group evidence in FF. Serum GUDCA was associated with metabolic indices, while FF GUDCA was associated with ovarian characteristics and response. No significant association with high‐quality embryo rate was observed. These findings warrant prospective validation.
- 1 January 2026
- Published by Wiley in International Journal of Endocrinology
- Vol. 2026 (1)
Open AccessGlycoursodeoxycholic Acid and Insulin Resistance in Women With Normoandrogenic Polyendocrine Metabolic Ovarian Syndrome Undergoing In Vitro Fertilization
Aim: To characterize paired serum and follicular fluid (FF) bile acids in normoandrogenic polyendocrine metabolic ovarian syndrome (NA‐PMOS) and investigate associations of glycoursodeoxycholic acid (GUDCA) with endocrine‐metabolic indices and in vitro fertilization (IVF) outcomes. Methods: This retrospective case–control study included 20 women with NA‐PMOS and 20 age‐comparable controls without PMOS undergoing IVF. Fifteen bile acids were measured in serum and FF. Analyses assessed group differences, metabolic and IVF associations, and discrimination between diagnostic groups. Results: Compared with controls without PMOS, women with NA‐PMOS had higher fasting insulin, triglycerides, and triglyceride–glucose (TyG) index and a lower high‐quality embryo rate. GUDCA was lower in NA‐PMOS in FF (137.01 vs. 332.60 nmol/L; p = 0.0004768; q = 0.007152) and serum (31.59 vs. 71.85 nmol/L; p = 0.03022; q = 0.2704). Apparent areas under the curve (AUCs) were 0.849 for FF, 0.713 for serum, and 0.871 for their combination. Serum GUDCA correlated inversely with TyG ( ρ = −0.582, p = 0.0028); the association persisted after adjustment for age, BMI, and diagnostic group ( β = −0.348, p = 0.0415). Within NA‐PMOS, serum GUDCA correlated inversely with fasting insulin and homeostasis model assessment of insulin resistance (HOMA‐IR). In the pooled cohort, FF GUDCA correlated inversely with baseline anti‐Müllerian hormone, total testosterone, and oocyte counts. GUDCA in neither matrix was significantly associated with high‐quality embryo rate. Conclusions: Lower GUDCA in serum and FF characterizes this exploratory IVF‐based NA‐PMOS sample, with stronger between‐group evidence in FF. Serum GUDCA was associated with metabolic indices, while FF GUDCA was associated with ovarian characteristics and response. No significant association with high‐quality embryo rate was observed. These findings warrant prospective validation.